Accentia Biopharmaceuticals, Inc. Balance Sheet as of September 30, 2010 (Unaudited)

Summary

This document is the unaudited balance sheet of Accentia Biopharmaceuticals, Inc. as of September 30, 2010. It details the company's assets, liabilities, and equity, including current assets like cash, accounts receivable, and inventories, as well as liabilities such as accounts payable, accrued expenses, and notes payable. The balance sheet also lists preferred stock issued and outstanding. This financial statement provides a snapshot of the company's financial position at the specified date.

EX-10.4 5 dex104.htm THE COMPANY'S BALANCE SHEET The Company's Balance Sheet

Exhibit 10.4

ACCENTIA BIOPHARMACEUTICALS, INC.


	September 30, 2010 (Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	556,392
Accounts receivable:
Trade, net of allowance for doubtful accounts of $10,031 at June 30, 2010 and September 30, 2009		1,287,366
Inventories		417,087
Unbilled receivables		151,303
Prepaid expenses and other current assets		243,998

Total current assets		2,656,146

Goodwill		893,000
Intangible assets		1,083,962
Furniture, equipment and leasehold improvements, net		154,434
Deferred finance costs, less current portion		16,077
Other assets		216,791

	$	5,020,410

LIABILITIES
Liabilities not subject to compromise:
Current liabilities:
Accounts payable	$	1,125,877
Accrued expenses		1,791,856
Unearned revenues		263,778
Notes payable, related parties		2,041,005
Customer deposits		134,613
Derivative liability		1,844,200

Total current liabilities		7,201,329

Liabilities subject to compromise		142,886,695
Total liabilities		150,058,024


Commitments and contingencies		—

Series A convertible redeemable preferred stock, $1.00 par value; 8,950 shares authorized; 7,529 shares issued and outstanding at June 30, 2010 and September 30, 2009		7,528,640